Position in NUVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$150,128
-$163,427 QoQ
Shares Held
34,995
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DME Capital Management, LP holds $86,884,794 across 6 Biotechnology names. NUVB ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
2,152,669 | $59,628,931 | |
| 2 | LKFT |
Lakefront Biotherapeutics NV
|
482,746 | $14,482,380 | |
| 3 | COYA |
Coya Therapeutics, Inc.
|
2,335,540 | $9,202,027 | |
| 4 | IMVT |
Immunovant, Inc.
|
93,520 | $2,323,036 | |
| 5 | GANX |
Gain Therapeutics, Inc.
|
566,130 | $1,098,292 | |
| 6 | NUVB |
Nuvation Bio Inc.
This page
|
34,995 | $150,128 |
All Filings in NUVB
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $150,128 | 34,995 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $313,555 | 34,995 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $129,481 | 34,995 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $68,240 | 34,995 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $61,591 | 34,995 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $93,086 | 34,995 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $80,138 | 34,995 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $102,185 | 34,995 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $127,381 | 34,995 | Shares | Other | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||